Cleveland Clinic Medical Dermatology Therapy Update III 2024
Include: 22 videos + 1 pdf, size: 13.2 GB
Target Audience: physicians, residents, fellows, allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine
Information:
Medical Dermatology Therapy Update III
Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases
Attend this CME-certified educational activity for a unique opportunity to update your knowledge
and understanding of both traditional and new therapeutic strategies for a range of critically
important medical dermatologic conditions, including rheumatology-dermatology overlap
diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria,
sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
By Participating, You Will Be Able To:
- Describe the cutaneous manifestations of rheumatological disorders in medical dermatology and their burden, and provide updates in their medical therapy updates and optimization.
- Summarize updates in therapeutic strategies and critically appraise the safety and efficacy of topical, biologic and small molecule therapies for managing medical dermatological diseases.
- Describe updates in the treatment of atopic dermatitis, psoriatic arthritis and psoriatic vulgaris.
- Provide updates in the medical treatment of advanced cutaneous malignancies, autoimmune blistering diseases and granulomatous diseases.
- Summarize strategies to optimize an interprofessional team approach to caring for patients with complex medical dermatologic diseases.
Who Should Attend?
This course is designed for physicians, pharmacists, nurses, nurse practitioners, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Topics:
- Agenda.pdf
Day 1 Present and Future Insights into the Pathogenesis of Cancer-Associated Dermatomyositis.mp4
Day 1 Present and Future Insights into the Pathogenesis of Cutaneous Lupus Erythematosus.mp4
Day 1 The Story of Extracorporeal Photopheresis.mp4
Day 1 The Story of Subacute Cutaneous Lupus Erythematosus and Amyopathic Dermatomyositis.mp4
Day 1 Update in Treatment of Cutaneous Lupus Erythematosus.mp4
Day 1 Update in Treatment of Cutaneous Vasculitis.mp4
Day 1 Update in Treatment of Fibrosing Skin Diseases.mp4
Day 2 Collaborative Strategies to Manage Patients on Major Systemic Medications Lessons Learned from Isotreinoin.mp4
Day 2 Communicating for Influence.mp4
Day 2 Present State and Future of Medical Dermatology Insights from Tenures as Editor-in-Chief of the JAAD and AAD President.mp4
Day 2 Shared Medical Appointments – a Team Approach to Improve Access and Patient Experience.mp4
Day 2 Update in Treatment of Chronic Urticaria.mp4
Day 2 Update in Treatment of Hidradenitis Suppurativa.mp4
Day 2 Update in Treatment of Inflammatory Alopecias.mp4
Day 2 Update in Treatment of Psoriasis Vulgaris.mp4
Day 2 Update in Treatment of Psoriatic Arthritis.mp4
Day 3 Artificial Intelligence in Medical Dermatology.mp4
Day 3 Update in Treatment of Advanced Non-Melanoma Skin Cancers.mp4
Day 3 Update in Treatment of Autoimmune Bullous Diseases.mp4
Day 3 Update in Treatment of Cutaneous irAEs Related to Cancer Immunotherapies.mp4
Day 3 Update in Treatment of Cutaneous T-cell Lymphomas.mp4
Day 3 Update in Treatment of Sarcoidosis and Granulomatous Diseases.mp4
